Telix Pharmaceuticals Begins Phase 3 Trial for Brain Cancer Therapy

Telix Pharmaceuticals has dosed the first patient in its Phase 3 clinical trial for a new brain cancer therapy. This marks a significant step in the development of potential treatments for glioblastoma.